ATGC Co., Ltd.

Private

SeoulHealthcare & Life Scienceshttps://atgcbio.com/

Last Round

Buyout/LBO

Jan 1, 2026

Est. Valuation

$59.3M

Total Funding Raised

$6.31M

Company Overview

ATGC Co., Ltd. is a biopharmaceutical company that develops novel botulinum toxin products and other therapeutic biologics for medical and aesthetic indications.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

biopharmaceutical R&Dbotulinum toxinbotoxdrug licensingmedical aestheticsbiotechrecombinant proteinosteoarthritis therapeuticsGLP-1 analogopen innovationdrug development pipelineB2B pharmabiotherapeuticsclinical developmentmilestone payments

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

ATGC Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

ATGC Co., Ltd. comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

ATGC Co., Ltd. Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Buyout/LBO	Jan 1, 2026
Series C	Jan 4, 2019

View all Funding Rounds

ATGC Co., Ltd. Investors

Notable investors and investment history

ATGC Co., Ltd. investors
Investor	Rounds
KIWOOM Securities Co., Ltd.	Series C
HB Investment	VC Round, Series C
Korea Development Bank	VC Round
VIG Partners	Buyout/LBO

View all Investors

ATGC Co., Ltd. Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

ATGC Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about ATGC Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul

Employee Range13

Year FoundedN/A

Last FundingJan 1, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.